Literature DB >> 19129184

Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation.

Anguo Liu1, Pallavi Garg, Shiqi Yang, Ping Gong, Manuel A Pallero, Douglas S Annis, Yuanyuan Liu, Antonino Passaniti, Dean Mann, Deane F Mosher, Joanne E Murphy-Ullrich, Simeon E Goldblum.   

Abstract

Thrombospondin (TSP) 1 is a trimeric multidomain protein that contains motifs that recognize distinct host cell receptors coupled to multiple signaling pathways. Selected TSP1-induced cellular responses are tyrosine kinase-dependent, and TSP1 contains epidermal growth factor (EGF)-like repeats. Specific receptor interactions or functions for the EGF-like repeats have not been identified. We asked whether one or more biological responses to TSP1 might be explained through EGF receptor (EGFR) activation. In A431 cells, TSP1 increased autophosphorylation of Tyr-1068 of EGFR in a dose- and time-dependent manner. The ability of TSP1 to activate EGFR was replicated by the tandem EGF-like repeats as a recombinant protein. The three EGF-like repeats alone produced a high level of Tyr-1068 phosphorylation. EGF-like repeats from TSP2 and TSP4 also activated EGFR. Tyr-1068 phosphorylation was less when individual EGF-like repeats were tested or flanking sequences were added to the three EGF-like repeats. TSP1 and its EGF-like repeats also increased phosphorylation of EGFR Tyr-845, Tyr-992, Tyr-1045, Tyr-1086, and Tyr-1173, activated phospholipase Cgamma, and increased cell migration. No evidence was found for binding of the EGF-like repeats to EGFR. Instead, EGFR activation in response to TSP1 or its EGF-like repeats required matrix metalloprotease activity, including activity of matrix metalloprotease 9. Access to the ligand-binding portion of the EGFR ectodomain was also required. These findings suggest release of an endogenous EGFR ligand in response to ligation of a second unknown receptor by the TSPs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129184      PMCID: PMC2649082          DOI: 10.1074/jbc.M809198200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Regulation of tyrosine kinase cascades by G-protein-coupled receptors.

Authors:  L M Luttrell; Y Daaka; R J Lefkowitz
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

Review 2.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity.

Authors:  K Bein; M Simons
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

4.  Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

Authors:  P O-charoenrat; H Modjtahedi; P Rhys-Evans; W J Court; G M Box; S A Eccles
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

5.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.

Authors:  N Prenzel; E Zwick; H Daub; M Leserer; R Abraham; C Wallasch; A Ullrich
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

Review 6.  Epidermal growth factor receptors: critical mediators of multiple receptor pathways.

Authors:  P O Hackel; E Zwick; N Prenzel; A Ullrich
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

7.  Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice.

Authors:  M Streit; P Velasco; L Riccardi; L Spencer; L F Brown; L Janes; B Lange-Asschenfeldt; K Yano; T Hawighorst; L Iruela-Arispe; M Detmar
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

8.  Physical characterization of the procollagen module of human thrombospondin 1 expressed in insect cells.

Authors:  T M Misenheimer; K G Huwiler; D S Annis; D F Mosher
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

9.  Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.

Authors:  J C Rodriguez-Manzaneque; T F Lane; M A Ortega; R O Hynes; J Lawler; M L Iruela-Arispe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

10.  Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.

Authors:  C S Swindle; K T Tran; T D Johnson; P Banerjee; A M Mayes; L Griffith; A Wells
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  28 in total

1.  NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.

Authors:  Alan S Cross; Sang Won Hyun; Alba Miranda-Ribera; Chiguang Feng; Anguo Liu; Chinh Nguyen; Lei Zhang; Irina G Luzina; Sergei P Atamas; William S Twaddell; Wei Guang; Erik P Lillehoj; Adam C Puché; Wei Huang; Lai-Xi Wang; Antonino Passaniti; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

Review 2.  Thrombospondins as key regulators of synaptogenesis in the central nervous system.

Authors:  W Christopher Risher; Cagla Eroglu
Journal:  Matrix Biol       Date:  2012-01-21       Impact factor: 11.583

3.  TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.

Authors:  Anguo Liu; Ping Gong; Sang W Hyun; Kent Z Q Wang; Elizabeth A Cates; Darren Perkins; Douglas D Bannerman; Adam C Puché; Vladimir Y Toshchakov; Shengyun Fang; Philip E Auron; Stefanie N Vogel; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

Review 4.  Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms.

Authors:  Mariya T Sweetwyne; Joanne E Murphy-Ullrich
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

5.  NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling.

Authors:  Erik P Lillehoj; Sang Won Hyun; Chiguang Feng; Lei Zhang; Anguo Liu; Wei Guang; Chinh Nguyen; Irina G Luzina; Sergei P Atamas; Antonino Passaniti; William S Twaddell; Adam C Puché; Lai-Xi Wang; Alan S Cross; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-01-13       Impact factor: 5.157

6.  Thrombospondin-4 is required for stretch-mediated contractility augmentation in cardiac muscle.

Authors:  Oscar H Cingolani; Jonathan A Kirk; Kinya Seo; Norimichi Koitabashi; Dong-Ik Lee; Genaro Ramirez-Correa; Djahida Bedja; Andreas S Barth; An L Moens; David A Kass
Journal:  Circ Res       Date:  2011-10-27       Impact factor: 17.367

7.  Diverse injurious stimuli reduce protein tyrosine phosphatase-μ expression and enhance epidermal growth factor receptor signaling in human airway epithelia.

Authors:  Sang W Hyun; Ian E Anglin; Anguo Liu; Shiqi Yang; John D Sorkin; Erik Lillehoj; Nicholas K Tonks; Antonino Passaniti; Simeon E Goldblum
Journal:  Exp Lung Res       Date:  2011-06-07       Impact factor: 2.459

8.  Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation.

Authors:  Pallavi Garg; Shiqi Yang; Anguo Liu; Manuel A Pallero; Donald J Buchsbaum; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-29       Impact factor: 5.464

Review 9.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

10.  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors:  George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal:  J Oncol       Date:  2009-12-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.